Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic

F Shah, D Logsdon, RA Messmann… - NPJ precision …, 2017 - nature.com
Abstract Reduction-oxidation factor 1-apurinic/apyrimidinic endonuclease (Ref-1/APE1) is a
critical node in tumor cells, both as a redox regulator of transcription factor activation and as …

Fanconi anemia pathway as a prospective target for cancer intervention

W Liu, A Palovcak, F Li, A Zafar, F Yuan, Y Zhang - Cell & bioscience, 2020 - Springer
Fanconi anemia (FA) is a recessive genetic disorder caused by biallelic mutations in at least
one of 22 FA genes. Beyond its pathological presentation of bone marrow failure and …

SynLethDB 2.0: a web-based knowledge graph database on synthetic lethality for novel anticancer drug discovery

J Wang, M Wu, X Huang, L Wang, S Zhang, H Liu… - Database, 2022 - academic.oup.com
Two genes are synthetic lethal if mutations in both genes result in impaired cell viability,
while mutation of either gene does not affect the cell survival. The potential usage of …

Computational methods, databases and tools for synthetic lethality prediction

J Wang, Q Zhang, J Han, Y Zhao, C Zhao… - Briefings in …, 2022 - academic.oup.com
Synthetic lethality (SL) occurs between two genes when the inactivation of either gene alone
has no effect on cell survival but the inactivation of both genes results in cell death. SL …

Optimal delivery of RNA interference by viral vectors for cancer therapy

B Wong, R Birtch, R Rezaei, T Jamieson, MJF Crupi… - Molecular Therapy, 2023 - cell.com
In recent years, there has been a surge in the innovative modification and application of the
viral vector-based gene therapy field. Significant and consistent improvements in the …

The Fanconi anemia ubiquitin E3 ligase complex as an anti-cancer target

MF Sharp, R Bythell-Douglas, AJ Deans, W Crismani - Molecular Cell, 2021 - cell.com
Agents that induce DNA damage can cure some cancers. However, the side effects of
chemotherapy are severe because of the indiscriminate action of DNA-damaging agents on …

Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer

D Hany, M Zoetemelk, K Bhattacharya… - Cellular and Molecular …, 2023 - Springer
Breast cancer is a persistent threat to women worldwide. A large proportion of breast
cancers are dependent on the estrogen receptor α (ERα) for tumor progression. Therefore …

Synthetic lethality-based identification of targets for anticancer drugs in the human signaling network

L Liu, X Chen, C Hu, D Zhang, Z Shao, Q Jin, J Yang… - Scientific Reports, 2018 - nature.com
Chemotherapy agents can cause serious adverse effects by attacking both cancer tissues
and normal tissues. Therefore, we proposed a synthetic lethality (SL) concept-based …

A multidimensional characterization of E3 ubiquitin ligase and substrate interaction network

D Chen, X Liu, T Xia, DS Tekcham, W Wang, H Chen… - IScience, 2019 - cell.com
E3 ubiquitin ligases (E3s) play a critical role in molecular and cellular mechanisms.
However, a large number of E3-substrate interactions (ESIs) remain unrevealed. Here, we …

Functional buffering via cell-specific gene expression promotes tissue homeostasis and cancer robustness

HK Lin, JH Cheng, CC Wu, FS Hsieh, C Dunlap… - Scientific Reports, 2022 - nature.com
Functional buffering that ensures biological robustness is critical for maintaining tissue
homeostasis, organismal survival, and evolution of novelty. However, the mechanism …